Gini Priyadharshini Jeyashanmugaraja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gini Priyadharshini Jeyashanmugaraja has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Christopher Winterbottom
Department of Pulmonology and Critical Care, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
2 shared publicationsDeborah Tosin Akanya
Department of Cardiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
2 shared publicationsEvgeny Shkolnik
Department of Cardiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
2 shared publicationsKristin Stawiarski
Department of Cardiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
2 shared publicationsStuart Zarich
Department of Cardiology, Yale New Haven Health Bridgeport Hospital, Bridgeport, CT, USA
2 shared publications- Adedoyin Akinlonu
Center for the Prevention of Cardiovascular Disease, Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA (Dr Akinlonu, Jindal, Fadzan, Garshick, Schwartzbard, Weintraub, Newman, Fisher, Goldberg and Berger)
1 shared publication
Latest Publications
- Open Access
- 1 July 2021
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2021 (7) , 281
Corrigendum to : One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram
When this paper first published, an author name was incorrectly given as ``Evgeny Shloknik''. This should have appeared as ``Evgeny Shkolnik''. This has now been corrected online
- 1 July 2021
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2021 (7) , 281
Open AccessCorrigendum to : One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram
When this paper first published, an author name was incorrectly given as ``Evgeny Shloknik''. This should have appeared as ``Evgeny Shkolnik''. This has now been corrected online
- Open Access
- 1 February 2021
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2021 (2) , 68-71
One clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram
A 63-year-old woman was admitted with severe respiratory distress requiring mechanical ventilation and shock requiring vasopressor support. She was found to have COVID-19 pneumonia. Focused cardiac ultrasound performed for evaluation of shock was significant for right ventricular dilation and dysfunction with signs of right ventricular pressure overload. Given worsening shock and hypoxemia systemic thrombolysis was administered for presumed massive pulmonary embolism with remarkable improvement of hemodynamics and respiratory failure. In next 24 h patient’s neurologic status deteriorated to the point of unresponsiveness. Emergent computed tomography showed multiple ischemic infarcts concerning for embolic etiology. Focused cardiac ultrasound with agitated saline showed large right to left shunt due to a patent foramen ovale. This was confirmed by transesophageal echocardiogram, 5 months later. This case highlights strengths of focused cardiac ultrasound in critical care setting and in patients with COVID-19 when access to other imaging modalities can be limited.
- 1 February 2021
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2021 (2) , 68-71
Open AccessOne clot after another in COVID-19 patient: diagnostic utility of handheld echocardiogram
A 63-year-old woman was admitted with severe respiratory distress requiring mechanical ventilation and shock requiring vasopressor support. She was found to have COVID-19 pneumonia. Focused cardiac ultrasound performed for evaluation of shock was significant for right ventricular dilation and dysfunction with signs of right ventricular pressure overload. Given worsening shock and hypoxemia systemic thrombolysis was administered for presumed massive pulmonary embolism with remarkable improvement of hemodynamics and respiratory failure. In next 24 h patient’s neurologic status deteriorated to the point of unresponsiveness. Emergent computed tomography showed multiple ischemic infarcts concerning for embolic etiology. Focused cardiac ultrasound with agitated saline showed large right to left shunt due to a patent foramen ovale. This was confirmed by transesophageal echocardiogram, 5 months later. This case highlights strengths of focused cardiac ultrasound in critical care setting and in patients with COVID-19 when access to other imaging modalities can be limited.
- Open Access
- 26 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Venous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which results in coronavirus disease 2019 (COVID-19) has had a devastating impact globally. Not much is fully understood about this disease. Acute respiratory distress syndrome (ARDS) appears to be the commonest complication among patients with COVID-19. However, venous thromboembolism (VTE) appears to be a common complication among patients with COVID-19 even with adequate anticoagulation during hospitalization. VTE may confer a poor outcome on its own or may exacerbate other common complications such as ARDS or cardiac injury. There are several diagnostic dilemmas with regards confirming VTE among patients with COVID-19 as there is a move to reduce the transfer of patients for angiographic studies or even venous Doppler ultrasonography because of the high transmissibility SARS-CoV-2. There is also the risk of worsening ARDS following fluid administration to prevent contrast nephropathy after angiographic studies. It is, therefore, crucial to understand the timing of VTE occurrence in the setting of COVID-19, identify strategies for early diagnosis of VTE, therapeutic options as well as prognostic implications of VTE in the setting of COVID-19.
- 26 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Open AccessVenous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) which results in coronavirus disease 2019 (COVID-19) has had a devastating impact globally. Not much is fully understood about this disease. Acute respiratory distress syndrome (ARDS) appears to be the commonest complication among patients with COVID-19. However, venous thromboembolism (VTE) appears to be a common complication among patients with COVID-19 even with adequate anticoagulation during hospitalization. VTE may confer a poor outcome on its own or may exacerbate other common complications such as ARDS or cardiac injury. There are several diagnostic dilemmas with regards confirming VTE among patients with COVID-19 as there is a move to reduce the transfer of patients for angiographic studies or even venous Doppler ultrasonography because of the high transmissibility SARS-CoV-2. There is also the risk of worsening ARDS following fluid administration to prevent contrast nephropathy after angiographic studies. It is, therefore, crucial to understand the timing of VTE occurrence in the setting of COVID-19, identify strategies for early diagnosis of VTE, therapeutic options as well as prognostic implications of VTE in the setting of COVID-19.